Plasticity in mast cell responses during bacterial infections

Current Opinion in Microbiology

Volumn 15, Issue 1, 2012, Pages 78-84

  Chan, Cheryl Y ^a   St John, Ashley L ^a,b   Abraham, Soman N ^a,b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CATHELICIDIN; CYTOKINE; PATTERN RECOGNITION RECEPTOR; POLYPEPTIDE ANTIBIOTIC AGENT; TOLL LIKE RECEPTOR;

ANTIBODY PRODUCTION; BACTERIAL INFECTION; BORDETELLA PERTUSSIS; CELL MEDIATED CYTOTOXICITY; CELLULAR IMMUNITY; CLOSTRIDIUM DIFFICILE; CYTOKINE PRODUCTION; DISEASE EXACERBATION; DISEASE SEVERITY; HELICOBACTER PYLORI; HOST PATHOGEN INTERACTION; HUMAN; INFECTION; INFLAMMATION; INFLAMMATORY DISEASE; LYMPHATIC DRAINAGE; LYMPHOCYTE PROLIFERATION; MAST CELL; MAST CELL DEGRANULATION; MEDIATOR RELEASE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PLEIOTROPY; REVIEW; SALMONELLA; STAPHYLOCOCCUS AUREUS; T LYMPHOCYTE ACTIVATION; VIBRIO CHOLERAE;

ANIMALS; BACTERIA; BACTERIAL INFECTIONS; HUMANS; MAST CELLS; MICE; MODELS, BIOLOGICAL;

BACTERIA (MICROORGANISMS);

EID: 84856106657     PISSN: 13695274     EISSN: 18790364     Source Type: Journal    
DOI: 10.1016/j.mib.2011.10.007     Document Type: Review

References (53)

1. Trinchieri G., Sher A. Cooperation of Toll-like receptor signals in innate immune defence. Nat Rev Immunol 2007, 7:179-190.
2. Supajatura V., Ushio H., Nakao A., Akira S., Okumura K., Ra C., Ogawa H. Differential responses of mast cell Toll-like receptors 2 and 4 in allergy and innate immunity. J Clin Invest 2002, 109:1351-1359.
3. Dietrich N., Rohde M., Geffers R., Kröger A., Hauser H., Weiss S., Gekara N.O. Mast cells elicit proinflammatory but not type I interferon responses upon activation of TLRs by bacteria. Proc Natl Acad Sci USA 2010, 107:8748-8753.
4. Malaviya R., Gao Z., Thankavel K., van der Merwe P.A., Abraham S.N. The mast cell tumor necrosis factor alpha response to FimH-expressing Escherichia coli is mediated by the glycosylphosphatidylinositol-anchored molecule CD48. Proc Natl Acad Sci USA 1999, 96:8110-8115.
5. Munoz S., Hernandez-Pando R., Abraham S.N., Enciso J.A. Mast cell activation by Mycobacterium tuberculosis: mediator release and role of CD48. J Immunol 2003, 170:5590-5596.
6. Rocha-de-Souza C.M., Berent-Maoz B., Mankuta D., Moses A.E., Levi-Schaffer F. Human mast cell activation by Staphylococcus aureus: interleukin-8 and tumor necrosis factor alpha release and the role of Toll-like receptor 2 and CD48 molecules. Infect Immun 2008, 76:4489-4497.
7. Leal-Berumen I., Snider D.P., Barajas-Lopez C., Marshall J.S. Cholera toxin increases IL-6 synthesis and decreases TNF-alpha production by rat peritoneal mast cells. J Immunol 1996, 156:316-321.
8. Meyer G.K., Neetz A., Brandes G., Tsikas D., Butterfield J.H., Just I., Gerhard R. Clostridium difficile Toxins A and B directly stimulate human mast cells. IAI 2007, 75:3868-3876.
9. Saito S., Okajima F., Molski T.F., Sha'afi R.I., Ui M., Ishizaka T. Effects of ADP-ribosylation of GTP-binding protein by pertussis toxin on immunoglobulin E-dependent and independent histamine release from mast cells and basophils. J Immunol 1987, 138:3927-3934.
10. Aceti A., Celestino D., Caferro M., Casale V., Citarda F., Conti E.M., Grassi A., Grilli A., Pennica A., Sciarretta F., et al. Basophil-bound and serum immunoglobulin E directed against Helicobacter pylori in patients with chronic gastritis. Gastroenterology 1991, 101:131-137.
11. Leung D.Y., Harbeck R., Bina P., Reiser R.F., Yang E., Norris D.A., Hanifin J.M., Sampson H.A. Presence of IgE antibodies to staphylococcal exotoxins on the skin of patients with atopic dermatitis. Evidence for a new group of allergens. J Clin Invest 1993, 92:1374-1380.
12. Qiao H., Andrade M.V., Lisboa F.A., Morgan K., Beaven M.A. FcepsilonR1 and toll-like receptors mediate synergistic signals to markedly augment production of inflammatory cytokines in murine mast cells. Blood 2006, 107:610-618.
13. Genovese A., Bouvet J.P., Florio G., Lamparter-Schummert B., Bjorck L., Marone G. Bacterial immunoglobulin superantigen proteins A and L activate human heart mast cells by interacting with immunoglobulin E. Infect Immun 2000, 68:5517-5524.
14. Nilsson G., Johnell M., Hammer C.H., Tiffany H.L., Nilsson K., Metcalfe D.D., Siegbahn A., Murphy P.M. C3a and C5a are chemotaxins for human mast cells and act through distinct receptors via a pertussis toxin-sensitive signal transduction pathway. J Immunol 1996, 157:1693-1698.
15. Mullaly S.C., Kubes P. The role of TLR2 in vivo following challenge with Staphylococcus aureus and prototypic ligands. J Immunol 2006, 177:8154-8163.
16. Sher A., Hein A., Moser G., Caulfield J.P. Complement receptors promote the phagocytosis of bacteria by rat peritoneal mast cells. Lab Invest 1979, 41:490-499.
17. Prodeus A.P., Zhou X., Maurer M., Galli S.J., Carroll M.C. Impaired mast cell-dependent natural immunity in complement C3-deficient mice. Nature 1997, 390:172-175.
18. Echtenacher B., Männel D.N., Hültner L. Critical protective role of mast cells in a model of acute septic peritonitis. Nature 1996, 381:75-77.
19. Malaviya R., Ikeda T., Ross E., Abraham S.N. Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-alpha. Nature 1996, 381:77-80.
20. Thakurdas S.M., Melicoff E., Sansores-Garcia L., Moreira D.C., Petrova Y., Stevens R.L., Adachi R. The mast cell-restricted tryptase mMCP-6 has a critical immunoprotective role in bacterial infections. J Biol Chem 2007, 282:20809-20815.
21. Ketavarapu J.M., Rodriguez A.R., Yu J.J., Cong Y., Murthy A.K., Forsthuber T.G., Guentzel M.N., Klose K.E., Berton M.T., Arulanandam B.P. Mast cells inhibit intramacrophage Francisella tularensis replication via contact and secreted products including IL-4. Proc Natl Acad Sci USA 2008, 105:9313-9318.
22. Sutherland R.E., Olsen J.S., McKinstry A., Villalta S.A., Wolters P.J. Mast cell IL-6 improves survival from Klebsiella pneumonia and sepsis by enhancing neutrophil killing. J Immunol 2008, 181:5598-5605.
23. Kunder C.A., St.John A.L., Li G., Leong K.W., Berwin B., Staats H.F., Abraham S.N. Mast cell-derived particles deliver peripheral signals to remote lymph nodes. J Exp Med 2009, 206:2455-2467.
24. Shelburne C.P., Nakano H., St.John A., Chan C., McLachlan J.B., Gunn M.D., Staats H.F., Abraham S.N. Mast cells augment adaptive immunity by orchestrating dendritic cell trafficking through infected tissues. Cell Host Microbe 2009, 6:331-342.
25. Dawicki W., Jawdat D.W., Xu N., Marshall J.S. Mast cells, histamine, and IL-6 regulate the selective influx of dendritic cell subsets into an inflamed lymph node. J Immunol 2010, 184:2116-2123.
26. Meng H., Tonnesen M.G., Marchese M.J., Clark R.A., Bahou W.F., Gruber B.L. Mast cells are potent regulators of endothelial cell adhesion molecule ICAM-1 and VCAM-1 expression. J Cell Phys 2005, 160:40-53.
27. Stelekati E., Bahri R., D'Orlando O., Orinska Z., Mittrücker H.W., Langenhaun R., Glatzel M., Bollinger A., Paus R., Bulfone-Paus S. Mast cell-mediated antigen presentation regulates CD8+ T cell effector functions. Immunity 2009, 31:665-676.
28. Di Nardo A., Yamasaki K., Dorschner R.A., Lai Y., Gallo R.L. Mast cell cathelicidin antimicrobial peptide prevents invasive group A Streptococcus infection of the skin. J Immunol 2008, 180:7565-7573.
29. Li G., Domenico J., Jia Y., Lucas J.J., Gelfand E.W. NF-kappaB-dependent induction of cathelicidin-related antimicrobial peptide in murine mast cells by lipopolysaccharide. Int Arch Allergy Immunol 2009, 150:122-132.
30. Cruse G., Fernandes V.E., de Salort J., Pankhania D., Marinas M.S., Brewin H., Andrew P.W., Bradding P., Kadioglu A. Human lung mast cells mediate pneumococcal cell death in response to activation by pneumolysin. J Immunol 2010, 184:7108-7115.
31. Swindle E.J., Metcalfe D.D., Coleman J.W. Rodent and human mast cells produce functionally significant intracellular reactive oxygen species but not nitric oxide. J Biol Chem 2004, 279:48751-48759.
32. Xu X., Zhang D., Lyubynska N., Wolters P.J., Killeen N.P., Baluk P., McDonald D.M., Hawgood S., Caughey G.H. Mast cells protect mice from Mycoplasma pneumonia. Am J Respir Crit Care Med 2006, 173:219-225.
33. Michels N.M., Chu H.W., LaFasto S.C., Case S.R., Minor M.N., Martin R.J. Mast cells protect against airway Mycoplasma pneumoniae under allergic conditions. Clin Exp Allergy 2010, 40:1406-1413.
34. Mager M., Lammer V., Siebenhaar F., Zuberbier T., Metz M., Maurer M. Non-pathogenic commensal Escherichia coli can inhibit degranulation of mast cells. Exp Dermatol 2008, 17:427-435.
35. Mielcarek N., Hörnquist E.H., Johansson B.R., Locht C., Abraham S.N., Holmgren J. Interaction of Bordetella pertussis with mast cells, modulation of cytokine secretion by pertussis toxin. Cell Microbiol 2001, 3:181-188.
36. Jenkins C.E., Swiatoniowski A., Issekutz A.C., Lin T.J. Pseudomonas aeruginosa exotoxin A induces human mast cell apoptosis by a caspase-8 and -3-dependent mechanism. J Biol Chem 2004, 279:37201-37207.
37. Carlos D., Frantz F.G., Souza-Júnior D.A., Jamur M.C., Oliver C., Ramos S.G., Quesniaux V.F., Ryffel B., Silva C.L., Bozza M.T., Faccioli L.H. TLR2-dependent mast cell activation contributes to the control of Mycobacterium tuberculosis infection. Microbes Infect 2009, 11:770-778.
38. Werfel T. The role of leukocytes, keratinocytes, and allergen-specific IgE in the development of atopic dermatitis. J Invest Dermatol 2009, 129:1878-1891.
39. Lin T.J., Garduno R., Boudreau R.T., Issekutz A.C. Pseudomonas aeruginosa activates human mast cells to induce neutrophil transendothelial migration via mast cell-derived IL-1 alpha and beta. J Immunol 2002, 169:4522-4530.
40. Hofman V., Lassalle S., Selva E., Kalem K., Steff A., Hebuterne X., Sicard D., Auberger P., Hofman P. Involvement of mast cells in gastritis caused by Helicobacter pylori: a potential role in epithelial cell apoptosis. J Clin Pathol 2007, 60:600-607.
41. Metz M., Magerl M., Kuhl N.F., Valeva A., Bhakdi S., Maurer M. Mast cells determine the magnitude of bacterial toxin-induced skin inflammation. Exp Dermatol 2009, 18:160-166.
42. Supajatura V., Ushio H., Wada A., Yahiro K., Okumura K., Ogawa H., Hirayama T., Ra C. Cutting edge: VacA, a vacuolating cytotoxin of Helicobacter pylori, directly activates mast cells for migration and production of proinflammatory cytokines. J Immunol 2002, 168:2603-2607.
43. Ghildyal N., McNeil H.P., Gurish M.F., Austen K.F., Stevens R.L. Transcriptional regulation of the mucosal mast cell-specific protease gene, MMCP-2, by interleukin 10 and interleukin 3. J Biol Chem 1992, 267:8473-8477.
44. Piliponsky A.M., Chen C.C., Grimbaldeston M.A., Burns-Guydish S.M., Hardy J., Kalesnikoff J., Contag C.H., Tsai M., Galli S.J. Mast cell-derived TNF can exacerbate mortality during severe bacterial infections in C57BL/6-KitW-sh/W-sh mice. Am J Pathol 2010, 176:926-938.
45. Ramos L., Peña G., Cai B., Deitch E.A., Ulloa L. Mast cell stabilization improves survival by preventing apoptosis in sepsis. J Immunol 2010, 185-:709-716.
46. Seeley E.J., Sutherland R.E., Kim S.S., Wolters P.J. Systemic mast cell degranulation increases mortality during polymicrobial septic peritonitis in mice. J Leukoc Biol 2011, 90.
47. McLachlan J.B., Shelburne C.P., Hart J.P., Pizzo S.V., Goyal R., Brooking-Dixon R., Staats H.F., Abraham S.N. Mast cell activators: a new class of highly effective vaccine adjuvants. Nat Med 2008, 14:536-541.
48. Staats H.F., Fielhauer J.R., Thompson A.L., Tripp A.A., Sobel A.E., Maddaloni M., Abraham S.N., Pascual D.W. Mucosal targeting of a BoNT/A subunit vaccine adjuvanted with a mast cell activator enhances induction of BoNT/A neutralizing antibodies in rabbits. PLoS One 2009, 6:e16532.
49. McGowen A.L., Hale L.P., Shelburne C.P., Abraham S.N., Staats H.F. The mast cell activator compound 48/80 is safe and effective when used as an adjuvant for intradermal immunization with Bacillus anthracis protective antigen. Vaccine 2009, 27:3544-3552.
50. Estelle F., Simons R. Advances in H1-antihistamines. NEJM 2004, 351:2203-2217.
51. Lipworth B.J. Leukotriene-receptor antagonists. Lancet 1999, 353:57-62.
52. Colombel J.F., Sandborn W.J., Reinisch W., Mantzaris G.J., Kornbluth A., Rachmilewitz D., Lichtiger S., D'Haens G., Diamond R.H., Broussard D.L., et al. Infliximab, Azathioprine, or combination therapy for Crohn's disease. NEJM 2010, 362:1383-1395.
53. Feng B.S., He S.H., Zheng P.Y., Wu L., Yang P.C. Mast cells play a crucial role in Staphylococcus aureus peptidoglycan-induced diarrhea. Am J Pathol 2007, 171:537-547.